The invited speakers are:
Prof.dr. Lana Kandalaft (Ludwig Institute for Cancer Research, Lausanne, Switzerland) - “Mobilising antitumor immunity: Lessons from ovarian cancer.”
Prof.dr. Jolanda de Vries(Department of Tumor Immunology, Radboudumc, Nijmegen, The Netherlands) - “Dendritic cell-based vaccination against cancer.”
Prof.dr. Alexander Eggermont (Gustave Roussy, University of Paris-Sud) -“Immunotherapy development in solid tumors: where do lessons from melanoma take us?”
Dr. Jurjen Tel (Department of Biomedical Engineering, Laboratory of Immunoengineering, Technical University Eindhoven, The Netherlands) - “Single cell analysis reveals functional heterogeneity within plasmacytoid dendritic cells and identifies environmental cues that drive type I IFN production.”
In addition to our guest speakers a number of abstract will be selected for oral presentation. The final program is therefore not yet available.